Systems Immunology: Revealing Influenza Immunological Imprint.

artificial intelligence data mining influenza influenza vaccines machine learning multi-omics integrative analysis protective immunity systems immunology

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
20 05 2021
Historique:
received: 14 04 2021
revised: 19 05 2021
accepted: 19 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 17 8 2021
Statut: epublish

Résumé

Understanding protective influenza immunity and identifying immune correlates of protection poses a major challenge and requires an appreciation of the immune system in all of its complexity. While adaptive immune responses such as neutralizing antibodies and influenza-specific T lymphocytes are contributing to the control of influenza virus, key factors of long-term protection are not well defined. Using systems immunology, an approach that combines experimental and computational methods, we can capture the systems-level state of protective immunity and reveal the essential pathways that are involved. New approaches and technological developments in systems immunology offer an opportunity to examine roles and interrelationships of clinical, biological, and genetic factors in the control of influenza infection and have the potential to lead to novel discoveries about influenza immunity that are essential for the development of more effective vaccines to prevent future pandemics. Here, we review recent developments in systems immunology that help to reveal key factors mediating protective immunity.

Identifiants

pubmed: 34065617
pii: v13050948
doi: 10.3390/v13050948
pmc: PMC8160800
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI057229
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI090019
Pays : United States

Références

Cell. 2015 Jan 15;160(1-2):37-47
pubmed: 25594173
Proteins. 2020 Mar;88(3):397-413
pubmed: 31603244
Genome Biol. 2013 May 29;14(5):205
pubmed: 23731483
PLoS Pathog. 2011 Nov;7(11):e1002381
pubmed: 22102819
Sci Immunol. 2017 Aug 25;2(14):
pubmed: 28842433
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6313-8
pubmed: 11344265
Emerg Infect Dis. 2017 Jul;23(8):1332-1340
pubmed: 28580899
Science. 2020 Sep 25;369(6511):
pubmed: 32973003
Nature. 2009 Jun 25;459(7250):1122-5
pubmed: 19516283
J Exp Med. 2008 Dec 22;205(13):3119-31
pubmed: 19047440
Nat Immunol. 2011 Jul 10;12(8):786-95
pubmed: 21743478
Cell. 2014 Apr 10;157(2):499-513
pubmed: 24725414
Lancet. 2013 Jun 1;381(9881):1916-25
pubmed: 23623390
Science. 2017 Oct 6;358(6359):58-63
pubmed: 28983043
BMC Immunol. 2008 Mar 16;9:8
pubmed: 18366636
Nat Rev Drug Discov. 2019 Jun;18(6):463-477
pubmed: 30976107
Nat Med. 2012 Jan 29;18(2):274-80
pubmed: 22286307
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Sci Transl Med. 2013 Mar 13;5(176):176ra32
pubmed: 23486778
Circulation. 2015 Nov 17;132(20):1920-30
pubmed: 26572668
Int J Infect Dis. 2008 May;12(3):233-8
pubmed: 17913533
Curr Protoc Cytom. 2013 Jan;Chapter 1:Unit1.27
pubmed: 23292705
J Clin Microbiol. 1985 Aug;22(2):259-64
pubmed: 4031039
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Nat Med. 2021 Jan;27(1):125-135
pubmed: 33432170
Genes Immun. 2004 Mar;5(2):122-9
pubmed: 14737096
Nature. 2017 Jul 6;547(7661):94-98
pubmed: 28636589
Nat Immunol. 2009 Jan;10(1):116-125
pubmed: 19029902
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70
pubmed: 19918065
J Infect Dis. 2017 Mar 1;215(5):740-749
pubmed: 28007925
J Immunol. 2019 Aug 1;203(3):749-759
pubmed: 31201239
Nature. 1978 May 18;273(5659):238-9
pubmed: 306072
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74
pubmed: 24367114
N Engl J Med. 2004 Mar 18;350(12):1179-88
pubmed: 14985470
Immunol Cell Biol. 2017 Jul;95(6):525-530
pubmed: 28294138
J Infect Dis. 1977 May;135(5):714-9
pubmed: 300761
N Engl J Med. 2013 Feb 14;368(7):589-92
pubmed: 23343038
J Immunol. 2001 Sep 15;167(6):3293-9
pubmed: 11544317
Retrovirology. 2017 Dec 21;14(1):57
pubmed: 29268769
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
Mol Syst Biol. 2013 Apr 16;9:659
pubmed: 23591775
Nat Med. 2013 Oct;19(10):1305-12
pubmed: 24056771
Nat Rev Genet. 2015 Jun;16(6):321-32
pubmed: 25948244
Immunity. 2015 Dec 15;43(6):1186-98
pubmed: 26682988
BMC Syst Biol. 2014;8 Suppl 2:I1
pubmed: 25032990
Front Cell Infect Microbiol. 2019 Apr 17;9:107
pubmed: 31065546
Science. 2011 May 6;332(6030):687-96
pubmed: 21551058
J Hyg (Lond). 1972 Dec;70(4):767-77
pubmed: 4509641
Nat Rev Genet. 2019 May;20(5):257-272
pubmed: 30696980
Dev Biol (Basel). 2003;115:63-73
pubmed: 15088777
Sci Data. 2018 Feb 27;5:180015
pubmed: 29485622
Cell Rep. 2018 Nov 13;25(7):1995
pubmed: 30428364
Trends Immunol. 2012 Jul;33(7):323-32
pubmed: 22476049
Immunity. 2012 Jan 27;36(1):142-52
pubmed: 22265676
Sci Data. 2019 Oct 21;6(1):214
pubmed: 31636302
Lancet. 2008 Apr 26;371(9622):1464-75
pubmed: 18440429
Sci Transl Med. 2013 Feb 6;5(171):171ra19
pubmed: 23390249
Vaccine. 2015 Sep 29;33(40):5294-301
pubmed: 25858860
Eur J Immunol. 2019 Feb;49(2):212-220
pubmed: 30653669
Trends Immunol. 2020 Jun;41(6):457-465
pubmed: 32340868
Nat Med. 2004 Dec;10(12 Suppl):S82-7
pubmed: 15577936
Nat Immunol. 2014 Feb;15(2):128-35
pubmed: 24448570
N Engl J Med. 2009 Nov 12;361(20):2000-1
pubmed: 19907052
Nat Rev Microbiol. 2021 Apr 6;:
pubmed: 33824495
Nat Rev Immunol. 2019 Jun;19(6):383-397
pubmed: 30837674
Patterns (N Y). 2021 Jan 08;2(1):100178
pubmed: 33511368
Nature. 2004 Oct 7;431(7009):703-7
pubmed: 15470432
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1049-54
pubmed: 24395804
J Infect. 2015 Feb;70(2):187-96
pubmed: 25224643
PLoS One. 2011 Apr 21;6(4):e17919
pubmed: 21533034
Cell Host Microbe. 2015 Mar 11;17(3):295-300
pubmed: 25766291

Auteurs

Adriana Tomic (A)

Oxford Vaccine Group, University of Oxford, Oxford OX3 7LJ, UK.

Andrew J Pollard (AJ)

Oxford Vaccine Group, University of Oxford, Oxford OX3 7LJ, UK.
NIHR Oxford Biomedical Research Center, Oxford OX3 7LJ, UK.

Mark M Davis (MM)

Institute of Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA 94304, USA.
Department of Microbiology and Immunology, School of Medicine, Stanford University, Stanford, CA 94304, USA.
Howard Hughes Medical Institute, Stanford University, Stanford, CA 94304, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH